Oncology
Lenvaliant 4
Capsule — 4mg
WHO-GMP
Product Overview
Lenvatinib 4 mg capsules are a targeted anticancer medication categorized as a multi-targeted tyrosine kinase inhibitor (TKI)
Indications
Lenvatinib 4 mg capsules (IP) are oral anti-cancer medicines used to treat advanced thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer).
Dosage Forms & Strength
Available Forms
Capsule
Strength
4mg
Regulatory Approvals
WHO-GMP